Angel News

Back to Homepage

10th September 2021 - 0 comments

Cambridge University biotech spinout PetMedix announces £27m Series B

PetMedix™ has announced the completion of an oversubscribed $37M (£27M) Series B financing round that will be used to advance its innovative pipeline through clinical development. The investment brings two new investors into PetMedix: global technology company Tencent and Japanese corporation Kyoritsu Holdings alongside strong continued support from U.S.-based investor Digitalis Ventures, and British funds Parkwalk Advisors and Cambridge Innovation Capital.


Register / Login now to read full story

In order to read the full story we need you to be registered with us, please click the links below to login or register.

Login / Register

Add a comment:




Enter the characters in the image shown:

Back to Homepage